Search Clinical Trials

589,087 trials

NCT07644091
Recruiting
Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer PatientsMethodist Health System
NCT07646067
Not Yet RecruitingNot Applicable
Closed Loop Glucose Control in a Simulated ICU SettingEmory University
NCT07646197
RecruitingNot Applicable
Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver DiseaseHenry Ford Health System
NCT07645131
Not Yet RecruitingNot Applicable
Development of a Mobile Health Intervention to Support Functioning of Veterans With Substance Use DisordersVA Office of Research and Development
NCT07644325
RecruitingNot Applicable
Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament BiopsyClinique Saint Jean, France
NCT07644936
Not Yet Recruiting
Molecular Characterization of Autoimmune Hepatitis: A Lipidomic ApproachAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
NCT07646405
RecruitingNot Applicable
Combined Effects of NMES and LIRT on Muscle Strength, Girth, and Physical Endurance in the Geriatric PopulationRiphah International University
NCT07644377
Not Yet RecruitingPhase 3
Discontinuation Versus Continuation of Riociguat Monotherapy in Chronic Thromboembolic Pulmonary Hypertension Successfully Treated With Balloon Pulmonary AngioplastyAssistance Publique - Hôpitaux de Paris
NCT07644611
Not Yet Recruiting
Sleep, Mental Fatigue, and Performance in StudentsL.U.de.S. Sagl
NCT07645300
Not Yet RecruitingPhase 2
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD TrialMichael E. DeBakey VA Medical Center
NCT07645391
Recruiting
Targeted Early Detection Program in Men at High Genetic Risk for Prostate CancerNational Cancer Institute (NCI)
NCT07646548
Not Yet RecruitingPhase 1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsRegeneron Pharmaceuticals
NCT07645248
Not Yet RecruitingPhase 3
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)GlaxoSmithKline
NCT07646002
CompletedNot Applicable
Effectiveness of Balloon Blowing and Deep Breathing Exercise on Increasing Peripheral Oxygen Saturation in Patients With Chronic Obstructive Pulmonary DiseaseIndonesia University
NCT07645469
Not Yet RecruitingPhase 1
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaFred Hutchinson Cancer Center
NCT07644299
Not Yet RecruitingNot Applicable
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Concept StudyCiusss de L'Est de l'Île de Montréal
NCT07644897
RecruitingPhase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen University
NCT07645274
Not Yet RecruitingNot Applicable
Improving Mental Healthcare Outcomes for Minoritized Veterans Through a Peer-led, Patient Navigation Program (PARTNER-MH 2.0)Indiana University
NCT07646132
Not Yet RecruitingNot Applicable
Focal Extracorporeal Shock Wave Therapy With Two Different Dosing Regimens for Chronic Low Back PainArmando Tonatiuh Avila Garcia
NCT07645612
Not Yet RecruitingNot Applicable
A Just-in-Time Digital Learning Platform for Teacher Oral Health TrainingUniversiti Putra Malaysia